Related Experiment Video
Updated: Jul 17, 2026

Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells
Marina Pisano1, Gabriella Pagnan, Monica Loi
1Bio-molecular Chemistry Institute, National Research Council, Sassari, Italy. marina.pisano@icb.cnr.it
Background:
Malignant melanoma is one of the most aggressive skin cancer and chemotherapeutic agents currently in use are still unsatisfactory. Prevention and early diagnosis are the only effective tools against this tumour whose incidence and mortality rates are highly increased during the last decades in fair skin populations. Therefore the search for novel therapeutic approaches is warranted. Aim of this work was to identify and test new compounds with antiproliferative and cytotoxic activity on melanoma cells. We tested eugenol together with six natural and synthetic eugenol-related compounds for their capability to inhibit cell growth on primary melanoma cell lines established from patients' tissue samples.
Results:
Eugenol and isoeugenol monomers and their respective O-methylated forms did not show to inhibit melanoma cells proliferation. Conversely, the dimeric forms (biphenyls) showed some antiproliferative activity which was mild for dehydrodieugenol, higher for its O,O'-methylated form (O,O'-dimethyl-dehydrodieugenol), and markedly pronounced for the racemic mixture of the brominated biphenyl (6,6'-dibromo-dehydrodieugenol) (S7), being its enantiomeric form (S) the most effective compared to the other compounds. Such activity resulted to be selective against tumour cells, without affecting cultured normal human skin fibroblasts. Dose and time dependence curves have been obtained for the enantiomeric form S7-(S). Then IC50 and minimal effective doses and times have been established for the melanoma cell lines tested. TUNEL and phosphatidylserine exposure assays demonstrated the occurrence of apoptotic events associated with the antiproliferative activity of S7-(S). Cytotoxic activity and apoptosis induced by treating melanoma cells with eugenol-related biphenyls was partially dependent by caspase activation.
Conclusion:
Our findings demonstrate that the eugenol related biphenyl (S)-6,6'-dibromo-dehydrodieugenol elicits specific antiproliferative activity on neuroectodermal tumour cells partially triggering apoptosis and its activity should be further investigated on in vivo melanoma models in order to evaluate the real anticancer effectiveness on such tumour.
Insights
Researchers identified a novel compound, (S)-6,6'-dibromo-dehydrodieugenol, that selectively inhibits melanoma cell growth by inducing apoptosis. This eugenol-related biphenyl shows promise as a potential new therapy for aggressive skin cancer.
Area of Science:
- Oncology
- Dermatology
- Medicinal Chemistry
Background:
- Malignant melanoma is an aggressive skin cancer with limited treatment options.
- Current chemotherapeutic agents for melanoma are unsatisfactory.
- Novel therapeutic strategies are urgently needed to combat rising melanoma incidence and mortality.
Purpose of the Study:
- To identify and evaluate novel compounds for antiproliferative and cytotoxic activity against melanoma cells.
- To investigate the potential of eugenol and related compounds as anti-melanoma agents.
Main Methods:
- Primary melanoma cell lines were established from patient tissue samples.
- Eugenol and six related compounds were tested for their ability to inhibit cell growth.
- Antiproliferative and cytotoxic effects were assessed using dose-response and time-dependence studies.
- Apoptosis was evaluated using TUNEL and phosphatidylserine exposure assays.
- Caspase activation was investigated in relation to observed cytotoxicity.
Main Results:
- Eugenol and its simple derivatives showed no significant antiproliferative effects.
- Dimeric eugenol derivatives (biphenyls) exhibited antiproliferative activity.
- The brominated biphenyl (S)-6,6 -dibromo-dehydrodieugenol (S7-(S)) demonstrated marked antiproliferative and cytotoxic activity.
- This activity was selective for melanoma cells, sparing normal human skin fibroblasts.
- S7-(S) induced apoptosis in melanoma cells, partially through caspase activation.
Conclusions:
- The eugenol-related biphenyl (S)-6,6 -dibromo-dehydrodieugenol exhibits specific antiproliferative effects on neuroectodermal tumor cells.
- This compound partially triggers apoptosis, suggesting a potential mechanism of action.
- Further in vivo investigation is warranted to assess the anticancer effectiveness of (S)-6,6 -dibromo-dehydrodieugenol in melanoma models.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Antifungal Agents